Physician profile
Jon Cooper Wall
NPI 1407376163
$2,849.29
in general payments reported to CMS, 2019-2025
15 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $510 · 2021: $718 · 2022: $168 · 2023: $502 · 2024: $465 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,226.26 | 2019-2024 | Mesa Spinal System, Everest Spinal System, Serrato |
| Bioventus LLC | $308.71 | 2019-2022 | |
| Medical Device Business Services, INC. | $274.99 | 2020 | |
| Globus Medical, INC. | $170.48 | 2025 | Precice® Intramedullary Limb Lengthening System |
| Integra Lifesciences Corporation | $135.75 | 2019-2021 | |
| Depuy Synthes Sales INC. | $131.49 | 2020-2021 | |
| Next Science LLC | $118.48 | 2021 | |
| Zimmer Biomet Holdings, INC. | $111.52 | 2021 | |
| Axogen | $96.83 | 2022 | |
| Heron Therapeutics, INC. | $94.30 | 2021 | |
| Orthofix Medical, INC. | $90.84 | 2019-2020 | |
| Vb Spine LLC | $34.90 | 2025 | Yukon Oct Spinal System |
| Acera Surgical, INC. | $23.20 | 2022 | |
| Mallinckrodt Enterprises LLC | $16.32 | 2019 | |
| Si-Bone, INC. | $15.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.